Hugh M. Cole, Chief Business Officer at Jounce Therapeutics, Inc. (JNCE), sold 2,624 shares at $7.78 ($20K) on 2020-01-07, disclosed to the SEC on 2020-01-10.
Open-market sale of $20k JNCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JNCE | SELL | 2021-01-25 | $215K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $43K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |